» Articles » PMID: 28718448

Neuronal Activity in Ontogeny and Oncology

Overview
Journal Trends Cancer
Publisher Cell Press
Specialty Oncology
Date 2017 Jul 19
PMID 28718448
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The nervous system plays a central role in regulating the stem cell niche in many organs, and thereby pivotally modulates development, homeostasis, and plasticity. A similarly powerful role for neural regulation of the cancer microenvironment is emerging. Neurons promote the growth of cancers of the brain, skin, prostate, pancreas, and stomach. Parallel mechanisms shared in development and cancer suggest that neural modulation of the tumor microenvironment may prove a universal theme, although the mechanistic details of such modulation remain to be discovered for many malignancies. We review here what is known about the influences of active neurons on stem cell and cancer microenvironments across a broad range of tissues, and we discuss emerging principles of neural regulation of development and cancer.

Citing Articles

Hijacking of the nervous system in cancer: mechanism and therapeutic targets.

Zhang Y, Liao Q, Wen X, Fan J, Yuan T, Tong X Mol Cancer. 2025; 24(1):44.

PMID: 39915765 PMC: 11800603. DOI: 10.1186/s12943-025-02246-5.


Characterization of tumor suppressors and oncogenes evaluated from TCGA cancers.

Shen C, Geng R, Zhu S, Huang M, Liang J, Li B Am J Clin Exp Immunol. 2024; 13(4):187-194.

PMID: 39310123 PMC: 11411158. DOI: 10.62347/XMZW6604.


Targeting the peripheral neural-tumour microenvironment for cancer therapy.

Yaniv D, Mattson B, Talbot S, Gleber-Netto F, Amit M Nat Rev Drug Discov. 2024; 23(10):780-796.

PMID: 39242781 DOI: 10.1038/s41573-024-01017-z.


Interface-guided phenotyping of coding variants in the transcription factor RUNX1.

Ozturk K, Panwala R, Sheen J, Ford K, Jayne N, Portell A Cell Rep. 2024; 43(7):114436.

PMID: 38968069 PMC: 11345852. DOI: 10.1016/j.celrep.2024.114436.


Single-cell signatures identify microenvironment factors in tumors associated with patient outcomes.

Xue Y, Friedl V, Ding H, Wong C, Stuart J Cell Rep Methods. 2024; 4(6):100799.

PMID: 38889686 PMC: 11228369. DOI: 10.1016/j.crmeth.2024.100799.


References
1.
Jones D, Hutter B, Jager N, Korshunov A, Kool M, Warnatz H . Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet. 2013; 45(8):927-32. PMC: 3951336. DOI: 10.1038/ng.2682. View

2.
Ceyhan G, Demir I, Altintas B, Rauch U, Thiel G, Muller M . Neural invasion in pancreatic cancer: a mutual tropism between neurons and cancer cells. Biochem Biophys Res Commun. 2008; 374(3):442-7. DOI: 10.1016/j.bbrc.2008.07.035. View

3.
Ayala G, Dai H, Powell M, Li R, Ding Y, Wheeler T . Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res. 2008; 14(23):7593-603. DOI: 10.1158/1078-0432.CCR-08-1164. View

4.
Raufman J, Shant J, Xie G, Cheng K, Gao X, Shiu B . Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice. Carcinogenesis. 2011; 32(9):1396-402. PMC: 3165126. DOI: 10.1093/carcin/bgr118. View

5.
Mahe C, Bernhard M, Bobirnac I, Keser C, Loetscher E, Feuerbach D . Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines. Br J Pharmacol. 2004; 143(3):404-10. PMC: 1575348. DOI: 10.1038/sj.bjp.0705936. View